NEW YORK (GenomeWeb News) – Agilent Technologies and South Korea's Daegu Gyeongbuk Institute of Science and Technology (DGIST) today announced a collaboration focused on neurometabolomics research.
The collaboration kicked off with the opening of DGIST's new Neurometabolomics Excellence Research Center, which will use bioanalytical instruments from Agilent in its research directed at biomarkers for the early detection and diagnosis of brain diseases. Research conducted at the center will concentrate on changes in the metabolic materials of brain cells and their impact on the body's physiological functions and behaviors, Agilent said.
The center will be a hub for shared expertise, it added, including the research capabilities of the Johns Hopkins University Center for Metabolism and Obesity Research in the US, as well as major medical institutions and hospitals in Daegu.
Other neurometabolomics research projects planned at the center include those in the fields of medicine, neurobiology, statistics, computer science, and systems biology. There may also be opportunities for joint projects with major educational and medical institutions elsewhere in South Korea, as well as Singapore, and Australia, Agilent said.
Training and the development of scientists, researchers, and chemists will also be carried out at the center.